Document:

Exhibit 10.1

 

AMENDMENT
#2

TO
THE SECURITIES PURCHASE AGREEMENT AND

TO THE $1,5000,000 PROMISSORY NOTE

 

This
Amendment No. 2, dated January 30, 2017 (this "Amendment"), is by and between ActiveCare, Inc., a Delaware corporation
(the "Issuer") and JMJ Financial (the "Investor") (referred to collectively herein as the "Parties").

 

WHEREAS,
the Issuer and the Investor entered into a Securities Purchase Agreement Document SPA-09192016 (the "SPA") dated
as of September 19, 2016, pursuant to which the Issuer issued to the Investor a $1,500,000 Promissory Note (the "Note"),
a Warrant, and Origination Shares (All capitalized terms not otherwise defined herein shall have the meanings given such terms
in the SPA); and

 

WHEREAS,
the Issuer and the Investor previously entered into Amendment #1 to the SPA and the Note dated November 17, 2016.

 

NOW,
THEREFORE, the Issuer and the Investor agree to amend the SPA and the Note as follows:

		1.	Extension
                                         of Maturity Date. The sentence in the Note that commences with "The Maturity
                                         Date is the earlier of ..." shall be amended and replaced in its entirety with the
                                         following:

 

"The
Maturity Date is the earlier of March 15, 2017 or the third business day after the closing of the Issuer's securities offering
pursuant to the S-1 registration statement filed with the SEC on July 19, 2016 with a file number of 333-212589 (the "Registration
Statement")."

		2.	Origination
                                         Share Beneficial Ownership Limit. The following shall be inserted into the SPA as
                                         Section 1.3.3:

 

"1.3.3
Origination Share Beneficial Ownership Limitation. Unless otherwise agreed by both Parties, at no time will the Issuer issue to
the Investor such number of Origination Shares that would result in the Investor owning more than 9.99% of the number of shares
of common stock outstanding of the Issuer immediately after giving effect to the issuance of the Origination Shares (the "Beneficial
Ownership Limitation"). In the event that the number of Origination Shares deliverable to the Investor pursuant to Section
1.3.1 or 1.3.2 above would cause the Investor to exceed the Beneficial Ownership Limitation, the Issuer shall deliver to the Investor
such lesser number of Origination Shares the Investor requests that would result in the Investor owning less than the Beneficial
Ownership Limitation and the Issuer shall deliver to the Investor the remaining number of Origination Shares at such time as the
Investor notifies the Issuer that delivery of such remaining Origination Shares would not cause the Investor to exceed the Beneficial
Ownership Limitation."

 

ALL
OTHER TERMS AND CONDITIONS OF THE SPA AND THE NOTE, AS PREVIOUSLY AMENDED, REMAIN IN FULL FORCE AND EFFECT.

 

*           *           *

 

     

     

    

 

Please
indicate acceptance and approval of this Amendment #2 dated January 30, 2017 by signing below:

 

	/s/
    Jeffrey S. Peterson	 	/s/ JMJ
    Financial
	Jeffrey
    S. Peterson	 	JMJ
    Financial
	ActiveCare,
    Inc.	 	Its
    Principal
	Chief
    Executive OfficerExhibit 10.2

 

Waiver
and Clarification

 

JMJ
hereby waives all negative covenants in any and all agreements (warrant, note, etc.) in relation to the time of which the reverse
stock split was needing to be effectuated by, which is hereby agreed to as January 27, 2017. It is acknowledged that the reverse
stock split became effective in the marketplace the morning of January 27, 2017. As such, and by way of clarification, the warrants
issued on January 30, 2017 for 6,000,000 warrants are on a pre-split basis, which after taking into account the reverse stock
split amounts to 12,000 warrants.

 

	/s/ JMJ
    Financial	 
	JMJ
    Financial	 
	ITS:
    PrincipalExhibit 10.3

 

LOCK-UP
AGREEMENT

 

This
LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of ___________, 2017, by and between ActiveCare,
Inc. (the “Company”) and the undersigned Series G Convertible Preferred Stock holder, (the “Holder”).
For all purposes of this Agreement, “Holder” includes any affiliate or controlling person of Shareholder, and any
other agent, representative or other person with whom Holder is acting in concert.

 

W
I T N E S S E T H :

 

WHEREAS,
the Company approved the designation rights and preferences and privileges of it’s Series G Convertible Preferred Stock
(the “Series G Preferred”) on November 1, 2016; and

 

WHEREAS,
on_______, 2017, the Company filed the Certificate of Designations, Preferences and Rights of the Series G Preferred (the “Series
G Certificate of Designations”) with the State of Delaware;

 

WHEREAS,
on__________, 2017, the Company issued     shares of its Series G Preferred to Holder for services rendered;

 

WHEREAS,
pursuant to the Series G Certificate of Designations, such shares automatically convert (“Automatic Conversion”)
upon (i) the Company’s receipt of $50,000,000 or more in gross revenue in a single fiscal year, (ii) the sale of the Company
via asset purchase, stock sale, merger or other business combination in which the Company and/or its stockholders receive aggregate
gross proceeds of $25,000,000 or more, or (iii) the closing of an underwritten offering (the “Qualified Offering”)
by the Company pursuant to which the Company receives aggregate gross proceeds of at least Ten Million Dollars (US$10,000,000)
in consideration of the purchase of shares of common stock and/or which results in the listing of the Company’s common stock
on the Nasdaq National Market, the Nasdaq Capital Market, the New York Stock Exchange, or the NYSE MKT;

 

WHEREAS,
the Company and Holder have decided to enter into this Agreement, which shall restrict the public sale of the Holders shares of
common stock upon the triggering of an Automatic Conversion (the “Lock-Up Securities”), in accordance with
the terms below; and

 

WHEREAS,
this Agreement will be in addition to the terms of the lock up agreement that is required by the underwriter in connection with
the Qualified Offering (the “Underwriter Lock-Up Agreement”) .

 

NOW
THEREFORE, for good and valuable consideration, the sufficiency and receipt of which consideration is hereby acknowledged,
the Holder and the Company hereby agree as follows:

 

1.
Lock-Up Period.

 

The
Holder agrees that, from the date of an Automatic Conversion until the earlier of (i) the Company’s receipt of $25,000,000
or more in gross revenue in a single fiscal year (but in no event prior to twelve (12) months from the date of the final prospectus
with respect to the Qualified Offering, if any, even if such gross revenue threshold is attained prior to such date), or (ii)
eighteen (18) months from the date thereof (such period, the “Lock-Up Period”), the Holder shall be subject
to the lock-up restrictions set forth in Section 2 below.

 

     

     

    

 

2.
Lock-Up Restriction.

 

(a) Lock-Up.
During the Lock-Up Period, the Holder will not offer, sell, contract to sell, hypothecate or otherwise dispose of (or enter
into any transaction which is designed to, or might reasonably be expected to, result in the sale, hypothecation or
disposition (whether by actual or effective economic sale, hypothecation or disposition due to cash settlement or
otherwise) by the Holder or any affiliate of the Holder or any person in privity with the Holder or any affiliate of the
Holder), directly or indirectly, including the filing (or participation in the filing) of a registration statement with the
U.S. Securities and Exchange Commission in respect of, or establish or increase a put equivalent position or liquidate or
decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, with
respect to the Lock-Up Securities, unless such transaction is a Permitted Disposition (as defined below).

 

A
“Permitted Disposition” shall include the following: (a) transfers of Lock-Up Securities to a trust for the
benefit of the undersigned or as a bona fide gift, by will or intestacy or to a family member or trust for the benefit
of a family member of the undersigned (for purposes of this lock-up agreement, “family member” means any relationship
by blood, marriage or adoption, not more remote than first cousin); or (b) transfers of Lock-Up Securities to a charity or educational
institution; provided that in the case of any transfer pursuant to the foregoing clauses (a) or (b), (i) any such
transfer shall not involve a disposition for value, (ii) each transferee shall sign and deliver to the Company a lock-up agreement
substantially in the form of this lock-up agreement and (iii) no filing under Section 16(a) of the Exchange Act shall be
required or shall be voluntarily made.

 

(b)  
Stop Orders. The Holder further agrees that the Company is authorized to and the Company agrees to place “stop orders”
on its books to prevent any transfer of any Lock-Up Securities of the Company held by the Holder in violation of this Agreement.
The Company agrees not to allow any transaction to occur that is inconsistent with this Agreement.

 

3.
Miscellaneous.

 

(a)
At any time, and from time to time, after the signing of this Agreement, the Holder will execute such additional instruments
and take such action as may be reasonably requested by the Company to carry out the intent and purposes of this
Agreement.

 

(b)
This Agreement shall be governed by and construed in accordance with the laws of the State of Utah without regard to
principles of conflicts of laws. Any action brought by either party against the other concerning the transactions
contemplated by this Agreement shall be brought only in the state courts of Utah or in the federal courts located in the
state of Utah. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action
instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based on forum non
conveniens. The parties executing this Agreement and any other agreements referred to herein or delivered in connection
herewith agree to submit to the in personam jurisdiction of such courts and hereby irrevocably waive trial by jury. The
prevailing party shall be entitled to recover from the other party its reasonable attorneys’ fees and costs. In the
event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or
unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that
it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which
may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of
any agreement. 

 

    	 	2	 

     

    

 

(c)
Any and all notices or other communications given under this Agreement shall be in writing and shall be deemed to have been
duly given on (i) the date of delivery, if delivered in person to the addressee, (ii) the next business day if sent by
overnight courier, or (iii) three (3) days after mailing, if mailed within the continental United States, postage prepaid, by
certified or registered mail, return receipt requested, to the party entitled to receive same, at his or its address set
forth below:

 

If
to the Company:

 

With
a copy to (which shall not constitute notice):

 

If
to the Holder:

_________________

_________________

Tel
No.: _________________

 

(d)
The restrictions on transfer described in this Agreement are in addition to and cumulative with any other restrictions on
transfer otherwise agreed to by the Holder (including the Underwriter Lock-Up Agreement) or to which the Holder is subject to
by applicable law.

 

(e)
This Agreement shall be binding upon Holder, its legal representatives, successors and assigns.

 

(f)
This Agreement may be signed in counterparts and delivered by facsimile signature and delivered electronically.

 

(g)
The Company agrees not to take any action or allow any act to be taken which would be inconsistent with this
Agreement.

 

(h)
Nothing contained herein shall affect the validity or enforceability of the Underwriter Lock-Up Agreement which will not be
affected by the terms of this Agreement. To the extent there is any conflict between the terms of this Agreement and the
Underwriter Lock-Up Agreement, the Underwriter Lock-Up Agreement shall govern. 

 

(i)
Amendments. No provision of this Agreement may be amended except in a written instrument signed, by the Company and
Holder.  

 

[-signature
page follows-]

 

    	 	3	 

     

    

 

IN
WITNESS WHEREOF, and intending to be legally bound hereby, the parties hereto have executed this Agreement as of the day and
year first above written.

 

	 	HOLDER:
	 	 	 
	 	By:  	    
	 	 	an individual

 

 

	 	COMPANY:
	 	 	 
	 	ACTIVECARE,
    INC.
	 	 	 
	 	By:	 
	 	Name:	         
	 	Title:
     	

 

 

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]